News Formal

Eli Lilly: Breakthrough Trial Results Set Stage for Market Growth, Stock Gains

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 29 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 53%

Eli Lilly And Company ニュース

Novo Nordisk A/S

Stocks Analysis by Michael Lebowitz covering: Eli Lilly and Company, Novo Nordisk A/S. Read Michael Lebowitz's latest article on Investing.com

)), just completed a clinical side-by-side trial. After 72 weeks of testing on 750 obese or overweight adults with at least one medical problem, Eli Lilly came out ahead by a substantial margin. Per Eli Lilly:. On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% with Wegovy.

As shown, in both the average monthly cycle and the average Presidential election year, the market tends to weaken mid-month as mutual funds make their annual distributions. Furthermore, the BLS data has been revised to a much larger extent than ADP. The second graph below shows that small and medium-sized businesses continue to see weakening trends. To wit, small business payrolls fell by 17k, the fourth decline in the last five months. This is likely a function of higher interest rates having a much more significant impact on smaller companies.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 450. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Stocks making the biggest moves midday: JetBlue, Eli Lilly, Pure Storage, Salesforce and moreThese are the stocks posting the largest moves in midday trading.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks riseEvery weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
ソース: CNBC - 🏆 12. / 72 続きを読む »